During the past decade, WakeMed Clinical Research Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "WakeMed Clinical Research Institute" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator, "German Society for Thoracic and Cardiovascular Surgery" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "WakeMed Clinical Research Institute" are "Diabetes Mellitus, Type 2" (1 trials), "Mild Tricuspid Regurgitation" (1 trials), "Moderate Tricuspid Regurgitation" (1 trials) and "Tricuspid Regurgitation" (1 trials). Many other conditions were trialed in "WakeMed Clinical Research Institute" in a lesser frequency.

Most popular intervention types in "WakeMed Clinical Research Institute" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Canagliflozin 100 mg" (1 trials), "Canagliflozin 300 mg" (1 trials), "MVS" (1 trials), "Placebo" (1 trials) and "TV Annuloplasty" (1 trials). Other intervention names were less common.

The vast majority of trials in "WakeMed Clinical Research Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "WakeMed Clinical Research Institute". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in WakeMed Clinical Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in WakeMed Clinical Research Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".